Clinical Trial Update: The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial updates safety and efficacy of intralymphatic immunotherapy in adolescents and young adults with pollen allergy–associated rhinitis and asthma (P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Snippet

Sponsor: Karolinska Institutet | Conditions: Rhinitis, Asthma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-09-28